BAJAJ BROKING

Notification
No new Notification messages
Suraksha Diagnostic IPO is Open!
Apply for the Suraksha Diagnostic IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Innova Captab Ltd

Pharmaceuticals

Offer Period :

21st to 26th Dec 2023

Incorporated in January 2005, Innova Captab Limited operates in pharmaceutical contract development, domestic branded generics, and international branded generics. With a diverse product portfolio, Read more... the company serves a wide market, including prominent clients, and maintains an active presence in research and development.Read less

Innova Captab Ltd IPO Details

IPO Date 21st to 26th Dec 2023 Minimum Investment ₹14784 / 1 Lots
Listing Date 2023-12-29 Maximum Investment ₹192192 / 13 Lots
Face Value ₹10 per share Total Issue Size ₹570 Crores
Price ₹448 to ₹448 per share Fresh Issue ₹320 Crores
Lot Size 1 Lots (33 Shares) Offer For Sale ₹ 250
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 21st to 26th Dec 2023
Listing Date 2023-12-29
Face Value ₹10 per share
Price ₹448 to ₹448 per share
Lot Size 1 Lots (33 Shares)
Listing At BSE, NSE
Employee Discount ₹0 per share
Minimum Investment ₹14784 / 1 Lots
Maximum Investment ₹192192 / 13 Lots
Total Issue Size ₹570 Crores
Fresh Issue ₹320 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

21st Dec

IPO Starts

26th Dec

IPO Ends

27th Dec

Allotment Date

28th Dec

Initiation of Refund

28th Dec

Credit of Shares to Demat Account

29th Dec

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 65.94 50.89
Public Group 34.06 49.11

Innova Captab Ltd IPO Reservation

QIB Shares Offered 2544643(20%)
NII (HNI) Shares Offered 1908482(15%)
Retail Shares Offered 4453125(35%)
Anchor Investor Shares Offered 3816964(30%)
Total Shares Offered 12723214
Total Shares With Anchor Investor 12723214

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Innova Captab Ltd IPO Registrar

KFin Techologies Ltd
Phone Number + 91 40 6716 2222
Email Id innovacaptab.ipo@kfintech.com
Our Website www.kfintech.com

Innova Captab Ltd IPO Lead Manager

1. ICICI Securities Ltd

2. JM Financial Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Innova Captab Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Innova Captab Ltd

1. leading presence and one of the fastest growing CDMOs in the Indian pharmaceutical formulations market.

2. Well established relationships with its marquee CDMO customer base.

3. Highly efficient operations, including its world class manufacturing facilities and supply chain.

4. Rapidly growing domestic and international export branded generics businesses.

5. Strong R&D focus to build an increasingly complex product portfolio and attract and retain customers.

6. Consistent financial performance.

7. Experienced promoters and management team.

Risks Involved

1. Its Restated Consolidated Financial Information are not comparable on a period-to-period basis and to any future financial results that its may prepare and further, the company Pro Forma Condensed Consolidated Financial Information have not been prepared in accordance with generally accepted accounting principles including accounting standard and therefore, is subject to change and may not give an accurate picture of its factual results of operations or financial condition.

2. The company operate in a market that is highly competitive. Its compete to provide outsourced pharmaceutical manufacturing services or CDMO services and products, particularly for formulations, to pharmaceutical companies in India and other jurisdictions. In addition, its branded generic products compete with generic products of other suppliers in India and other jurisdictions.

3. The company has recently acquired Sharon, and does not yet know whether it will achieve the expected benefits from such acquisition, which could materially adversely affect its business, results of operation, cash flows and financial condition.

4. Its business is dependent and will continue to depend on the company manufacturing facilities, and its subject to certain risks in the company's manufacturing process such as the breakdown or failure of equipment, industrial accidents, severe weather conditions and natural disasters.

5. The company depends on a limited number of contract development and manufacturing organization ("CDMO") customers. Any reduction in the number of CDMO customers and adverse developments or inability to enter into or maintain relationships with these CDMO customers could have an adverse effect on its business, results of operations and financial condition.

6. Failure to comply with the quality requirements and technical specifications prescribed by its customers may lead to loss of business from such customers and could negatively impact its business, results of operations and financial condition, including cancellation of existing and future orders which may expose it to warranty claims.

7. Its funding requirements and proposed deployment of the Net Proceeds are based on management estimates and may be subject to change based on various factors, some of which are beyond its control.

8. The company has incurred significant capital expenditure during the last three Fiscal Years and the three months ended June 30, 2023. Its may require substantial financing for the company's business operations and planned capital expenditure and the failure to obtain additional financing on terms commercially acceptable to it may adversely affect its ability to grow and the company future profitability.

9. Its dependence on China, China SEZ and Hong Kong for the company raw material supplies exposes it to political, economic and social conditions in greater China.

10. Its business is capital intensive. Any insufficient cash flows from its operations or inability to borrow to meet the company working capital requirements, it may materially and adversely affect its business and results of operations.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 1320.88 704.41 575.47
Total Liabilities 1320.88 704.41 575.47
Total Expenses 964.27 843.78 717.69
Total Revenue 
1093.79 935.58 803.41
Profit After Tax 94.35 67.95 63.95
EBITDA 166.94 122.85 98.9
Adjusted EBITDA 0 0 0

Innova Captab Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2023-12-29 544067 INNOVACAP
INE0DUT01020
₹448 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹448 ₹448
Open ₹456.1 ₹452.1
Low ₹452 ₹452.1
High ₹547.3 ₹542.5
Low ₹452 ₹452.1

Frequently Asked Questions

What is Innova Captab Ltd IPO?

Answer Field

Innova Captab Ltd IPO is a Mainboard IPO of 1,27,23,214 equity shares of a face value of ₹10 aggregating up to ₹570 Crores. The issue is priced at ₹448 to ₹448 per share. The minimum order quantity is 33 Shares. The IPO opens on December 21, 2023, and closes on December 26, 2023. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Innova Captab Ltd IPO will open?

Answer Field

The Innova Captab Ltd IPO opens on December 21, 2023 and closes on December 26, 2023.

What is the lot size of Innova Captab Ltd?

Answer Field

Innova Captab Ltd lot size is 33 shares, and the minimum amount required is ₹14,784.

How to apply for Innova Captab Ltd IPO?

Answer Field

You can apply in Innova Captab Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Innova Captab Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Innova Captab Ltd IPO will be done on December 27, 2023, and the allotted shares will be credited to your demat account by December 28, 2023.

When is Innova Captab Ltd IPO listing date?

Answer Field

The Innova Captab Ltd listing date is December 29, 2023.

Who is the registrar of Innova Captab Ltd IPO?

Answer Field

The registrar of Innova Captab Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

ICICI Securities Ltd,JM Financial Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Innova Captab Ltd IPO?

Answer Field

The fresh issue size is ₹320 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Innova Captab Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 33 shares and ₹14,784 amount.

How can I approve the UPI mandate request for Innova Captab Ltd IPO?

Answer Field

To apply for Innova Captab Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Innova Captab Ltd?

Answer Field

The price of each Innova Captab Ltd share will be ranging in between ₹448 to ₹448 per share.

What is the cut-off time for the UPI mandate for Innova Captab Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 26, 2023.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • GANESH INFRAWORLD LIMITEDSME IPO

  • Bidding Dates

    29th Nov 2024 - 12th Dec 2024

  • Price Range

    ₹78.0 - 83.0

  • IPO Size

    ₹98,57,00,000

  • Apply Now
  • SURAKSHA DIAGNOSTIC LIMITEDMainboard IPO

  • Bidding Dates

    29th Nov 2024 - 12th Dec 2024

  • Price Range

    ₹420.0 - 441.0

  • IPO Size

    ₹8,46,25,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text